This episode currently has no reviews.
Submit ReviewAndy brings Harvard epidemiologist Bill Hanage back to discuss what the US can expect to see with the new Omicron subvariant BA.2. How will our bump compare to what we’re seeing in Europe? And how will people navigate it with the nationwide relaxation of vaccine and mask mandates? Plus, they revisit some of their previous conversation about the original strain of Omicron from six weeks ago to see how well their predictions held up.
Keep up with Andy on Twitter @ASlavitt and Instagram @andyslavitt.
Follow Bill @BillHanage on Twitter.
Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.
Support the show by checking out our sponsors!
Check out these resources from today’s episode:
Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.
For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.
See omnystudio.com/listener for privacy information.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review